英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

verbify

XDict

vt. 使动词化

PyDict

使动词化

WordNet (r) 3.0 (2006) (WordNet)

verbify
v 1: make into a verb; "'mouse' has been verbified by computer
users"

The Collaborative International Dictionary of English v.0.48 (gcide)

Verbify \Verb"i*fy\, v. t. [Verb -fy.]
To make into a verb; to use as a verb; to verbalize. [R.]
--Earle.
[1913 Webster]

请选择你想看的字典辞典：

单词	字典	翻译
Verbify	查看　Verbify　在百度字典中的解释	百度英翻中〔查看〕
Verbify	查看　Verbify　在Google字典中的解释	Google英翻中〔查看〕
Verbify	查看　Verbify　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://www.51zidian.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://www.51zidian.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

Home - Escient pharmaceuticals
Escient strives to discover and develop novel, life-changing medicines for patients We are committed to advancing innovative solutions for some of the most challenging, underserved disorders worldwide, where current treatments are either insufficient or nonexistent
Incyte signs deal to acquire Escient Pharmaceuticals
Incyte has agreed to acquire US-based Escient Pharmaceuticals and its assets, including two first-in-class small molecule antagonists targeting Mas-related G protein-coupled receptor X2 (MRGPRX2) for the treatment of various mast cell-mediated disorders
7. 5亿美元！Incyte收购Escient制药，获得两款MRGPR拮抗剂
4月23日，Incyte宣布以7 5亿美元现金收购Escient Pharmaceuticals，一家致力于开发针对全身免疫和神经免疫疾病的新型小分子疗法的临床阶段药物发现和开发公司，其中包括EP262，一种与Masrelated G蛋白偶联受体X2（MRGPRX2）相关的同类首创强效、高选择性、每日一次的小分子拮抗剂，以及EP547，一种口服MRGPRX4拮抗剂。 2018年5月，Escient完成4000万美元A轮融资，投资者包括The Column Group、5AM Ventures、Osage University Partners。
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Incyte is dolloping another deal onto its 2024 partnership plate, buying San Diego-based Escient Pharmaceuticals for $750 million The acquisition, announced Tuesday, would give Incyte ownership
Incyte to Acquire Escient Pharmaceuticals
Escient Pharmaceuticals Announces Positive Results From A Phase 1 Study of EP547, An MRGPRX4-Targeted Oral Therapy For Cholestatic And Uremic Pruritus Escient Pharmaceuticals July 14, 2021 Available at https: www escientpharma com news
Escient Pharmaceuticals - Crunchbase Company Profile Funding
Escient Pharmaceuticals is a provider of bio-technical research and development services intended to focus on the advancement of first-in-class G Protein-Coupled Receptor targeted drugs Its services focus on offering therapies for neuro-immuno-inflammatory and autoreactive diseases
Incyte Completes Acquisition of Escient Pharmaceuticals - Escient . . .
WILMINGTON, Del and SAN DIEGO, Cal – May 30, 2024 – Incyte (Nasdaq:INCY) today announced that it has completed its acquisition of Escient Pharmaceuticals, a clinical-stage drug discovery and development company advancing novel small molecule therapeutics for systemic immune and neuro-immune disorders
Incyte Announces Acquisition of Escient Pharmaceuticals and its . . .
WILMINGTON, Del SAN DIEGO-- (BUSINESS WIRE)--Incyte (Nasdaq:INCY) and Escient Pharmaceuticals, a clinical-stage drug discovery and development company advancing novel small molecule
Escient Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical . . .
Escient Pharmaceuticals is a privately held, clinical-stage biotechnology company that works on advancing novel and differentiated therapeutics for the potential treatment of an extensive array of neurosensory-inflammatory disorders
Incyte to Buy Escient Pharmaceuticals for $750 Million Cash (1)
Biopharmaceutical firm Incyte agreed to buy closely held Escient Pharmaceuticals for $750 million cash plus Escient’s net cash remaining at the close of the deal The acquisition of the clinical-stage drug development company is subject to clearance under the Hart-Scott-Rodino Act

中文字典-英文字典 2005-2009